To the Editor, Carbamazepine is an effective anticonvulsant and has a relatively low incidence of adverse effects, although it occasionally causes hema- tologic disorders. We herein describe a patient with carbamazepine- induced thrombocytopenic purpura that was investigated by pharma- cological, immunological and genomic assays.
Titolo: | Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis |
Autori: | |
Data di pubblicazione: | 2016 |
Stato di pubblicazione: | Pubblicato |
Rivista: | |
Abstract: | To the Editor, Carbamazepine is an effective anticonvulsant and has a relatively low incidence of adverse effects, although it occasionally causes hema- tologic disorders. We herein describe a patient with carbamazepine- induced thrombocytopenic purpura that was investigated by pharma- cological, immunological and genomic assays. |
Handle: | http://hdl.handle.net/11368/2878526 |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.bcmd.2016.05.001 |
URL: | http://www.sciencedirect.com/science/article/pii/S1079979616300468 |
Appare nelle tipologie: | 1.1 Articolo in Rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
carbamazepine.pdf | Documento in Versione Editoriale | Digital Rights Management non definito | Administrator Richiedi una copia | |
Manuscript.pdf | Bozza finale post-referaggio (post-print) | Digital Rights Management non definito | Open Access Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.